Mortality and Causes of Death in Patients With Polycythemia Vera
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on what polycythemia vera (PV) is and why it was important to understand mortality and causes of death among patients with PV.
Pharmacy Times® interviewed Brady Stein, MD, MHSc, an associate professor of medicine in hematology and oncology at the Feinberg School of Medicine at Northwestern University, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses a multicenter, noninterventional, prospective observational study of patients with polycythemia vera (PV) in US clinical practices, specifically in relation to mortality and causes of death.
In this video, Stein defines PV and explains why it was important to understand mortality and causes of death among patients with PV.
